These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 3585612

  • 21. Relationship between rate and extent of absorption of oral theophylline from Uniphyl brand of slow-release theophylline and resulting serum concentrations during multiple dosing.
    Milavetz G, Vaughan LM, Weinberger MM, Harris JB, Mullenix TA.
    J Allergy Clin Immunol; 1987 Nov; 80(5):723-9. PubMed ID: 3680816
    [Abstract] [Full Text] [Related]

  • 22. Inconsistent absorption from a sustained-release theophylline preparation during continuous therapy in asthmatic children.
    Rogers RJ, Kalisker A, Wiener MB, Szefler SJ.
    J Pediatr; 1985 Mar; 106(3):496-501. PubMed ID: 3973788
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of serum theophylline concentrations following administration of sustained-release beads in applesauce to asthmatic preschool children.
    Leeder JS, Robertson C, Correia J, Isles AF, Levison H, Macleod SM.
    Ann Allergy; 1986 Feb; 56(2):133-7. PubMed ID: 3946845
    [Abstract] [Full Text] [Related]

  • 24. Once-daily dosing of a new ultrasustained-release theophylline preparation.
    Van den Brande P, Nys J, Tjandramaga TB, Verhelst F, Demedts M.
    Respiration; 1987 Feb; 52(2):144-53. PubMed ID: 3671893
    [Abstract] [Full Text] [Related]

  • 25. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
    González MA, Straughan AB.
    Clin Ther; 1994 Feb; 16(5):804-14. PubMed ID: 7859239
    [Abstract] [Full Text] [Related]

  • 26. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D, Molz KH, Staib AH, Rietbrock N.
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [Abstract] [Full Text] [Related]

  • 27. Steady-state pharmacokinetics and effects of a new once-daily, slow-release theophylline capsule preparation in asthma.
    Williams PE, Alwazir YA, Routledge PA, Campbell IA.
    Br J Clin Pharmacol; 1986 Oct; 22(4):383-7. PubMed ID: 3768254
    [Abstract] [Full Text] [Related]

  • 28. The absorption characteristics of six sustained-release theophylline preparations.
    Sommers DK, van Wyk M, Meyer EC, Snyman JR, Moncrieff J.
    S Afr Med J; 1992 Jan 04; 81(1):20-2. PubMed ID: 1729729
    [Abstract] [Full Text] [Related]

  • 29. Selection of a slow-release theophylline product.
    Hendeles L, Weinberger M.
    J Allergy Clin Immunol; 1986 Oct 04; 78(4 Pt 2):743-51. PubMed ID: 3534055
    [Abstract] [Full Text] [Related]

  • 30. Update on the pharmacodynamics and pharmacokinetics of theophylline.
    Hendeles L, Massanari M, Weinberger M.
    Chest; 1985 Aug 04; 88(2 Suppl):103S-111S. PubMed ID: 3893922
    [Abstract] [Full Text] [Related]

  • 31. Pharmacokinetic properties of a new sustained-release theophylline preparation.
    Dahlqvist R, Billing B.
    Int J Clin Pharmacol Ther Toxicol; 1983 Feb 04; 21(2):69-72. PubMed ID: 6840927
    [Abstract] [Full Text] [Related]

  • 32. Sustained-release theophylline therapy for chronic childhood asthma.
    Bell T, Bigley J.
    Pediatrics; 1978 Sep 04; 62(3):352-8. PubMed ID: 704210
    [Abstract] [Full Text] [Related]

  • 33. Apparent inconsistent theophylline absorption from sustained release capsules.
    Uden DL, Schaber DE, Wyatt RA.
    Clin Pediatr (Phila); 1987 Jun 04; 26(6):285-7. PubMed ID: 3581636
    [Abstract] [Full Text] [Related]

  • 34. Serum profile and bioavailability of a controlled-release theophylline formulation for once-daily use: comparison with a 12-hr preparation.
    Cohen BM.
    J Asthma; 1984 Jun 04; 21(5):305-9. PubMed ID: 6389484
    [Abstract] [Full Text] [Related]

  • 35. The consistency of theophylline absorption from a sustained-release formulation in asthmatic children.
    Hill M, Haltom JR, Szefler SJ.
    Pharmacotherapy; 1988 Jun 04; 8(5):277-83. PubMed ID: 3255299
    [Abstract] [Full Text] [Related]

  • 36. Influence of food on the absorption of theophylline from a sustained release formulation (Somophyllin).
    Pedersen S, Møller-Petersen J.
    Clin Allergy; 1985 May 04; 15(3):253-9. PubMed ID: 4006175
    [Abstract] [Full Text] [Related]

  • 37. Circadian changes in the absorption and elimination of theophylline in patients with bronchial obstruction.
    Uematsu T, Follath F, Vozeh S.
    Eur J Clin Pharmacol; 1986 May 04; 30(3):309-12. PubMed ID: 3732366
    [Abstract] [Full Text] [Related]

  • 38. Bioavailability of a once daily-administered theophylline preparation. A comparison study.
    Mangura BT, Maniatis T, Abdel Rahman MS, Bartholf R, Lavietes MH.
    Chest; 1986 Oct 04; 90(4):566-70. PubMed ID: 3757567
    [Abstract] [Full Text] [Related]

  • 39. Clinical and pharmacokinetic concerns of 24-hour dosing with theophylline.
    Weinberger M.
    Ann Allergy; 1986 Jan 04; 56(1):2-12. PubMed ID: 3511775
    [Abstract] [Full Text] [Related]

  • 40. Steady-state evaluation of two controlled-release theophylline preparations in children.
    Tinkelman DG, Lutz CN, Crummie A, Harrison LI, McCarville SE, Bastyr MH.
    J Asthma; 1988 Jan 04; 25(1):27-31. PubMed ID: 3053601
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.